GORE EXCLUDER AAA Endoprosthesis PXC181200Recalls & reported problems
W. L. Gore & Associates, Inc. · Contralateral Leg · Class 3 · Implant
All models of GORE EXCLUDER AAA Endoprosthesis (81)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 3
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00733132610013), received between Aug 13, 2018 and Nov 28, 2023 — classified as 3 injuries.
The most frequently reported specific device problem is “Patient-Device Incompatibility” (1 report).
2 other recalls cover devices cleared under the same FDA submission (P020004); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
- Appropriate Device Problem Term/Code Not Available1
- Patient-Device Incompatibility1
Patient problems
- Aneurysm1
- Aneurysm expansion1
- Clinical Endoleak1
- No Code Available1
- Vasodilatation1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
InjuryNov 28, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
THE FOLLOWING WAS REPORTED TO GORE: ON (B)(6) 2010, THE PATIENT UNDERWENT AN ENDOVASCULAR TREATMENT OF AN ABDOMINAL AORTIC ANEURYSM USING GORE® EXCLUDER® AAA ENDOPROSTHESES. ON AN UNKNOWN DATE, A FOLLOW-UP EXAM REVEALED AN ANEURYSM ENLARGEMENT. IT WAS NOT CONFIRMED AN OBVIOUS ENDOLEAK BY AN IMAGE, BUT A DISTAL TYPE I ENDOLEAK WAS SUSPECTED BECAUSE THE RIGHT COMMON ILIAC ARTERY WAS DILATED (THE DIAMETER BECAME ABOUT 20 MM). ON (B)(6) 2023, A REINTERVENTION WAS PERFORMED. THE RIGHT INTERNAL ILIAC ARTERY WAS EMBOLIZED AND A CONTRALATERAL LEG ENDOPROSTHESIS WAS IMPLANTED TO EXTEND THE RIGHT LEG TO THE RIGHT EXTERNAL ILIAC ARTERY. THERE WAS NO ENDOLEAK AND THE PROCEDURE WAS CONCLUDED.
Patient problems: Aneurysm expansion; Clinical Endoleak; Vasodilatation
MAUDE report 18223154 ↗InjuryNov 20, 2018Patient-Device Incompatibility; Patient-Device Incompatibility
THE FOLLOWING INFORMATION WAS REPORTED TO GORE: ON (B)(6) 2012, THIS PATIENT UNDERWENT ENDOVASCULAR TREATMENT FOR AN ABDOMINAL AORTIC ANEURYSM WITH A DIAMETER MEASURING 52 MM AND WAS TREATED WITH GORE® EXCLUDER® AAA ENDOPROSTHESES. ON (B)(6) 2013, COMPUTED TOMOGRAPHY ANGIOGRAPHY IMAGING (CTA) IDENTIFIED THE ANEURYSM MEASURING 46 MM. ON (B)(6) 2014, AND ON (B)(6) 2016, CT IMAGING IDENTIFIED THE ANEURYSM MEASURING 48 MM AND 50 MM, RESPECTIVELY. DURING FOLLOW-UP CTA IMAGING ON (B)(6) 2018, IT WAS FOUND THAT THE GORE® EXCLUDER® CONTRALATERAL LEG COMPONENT PXC181200 / (B)(4) IMPLANTED ON THE RIGHT PATIENT SIDE HAD SHORT SHORTENED DUE TO DISEASE PROGRESSION. A TYPE 1B ENDOLEAK WAS HOWEVER NOT REPORTED. ADDITIONALLY, AN ANEURYSM DIAMETER OF 51 MM WAS CONFIRMED. ON (B)(6) 2018, AN ADDITIONAL STENT WAS IMPLANTED INTO THE RIGHT COMMON ILIAC ARTERY TO EXTEND THE PXC181200 COMPONENT TO AGAIN PROVIDE ADEQUATE SEAL.
Patient problems: No Code Available
MAUDE report 8088699 ↗InjuryAug 13, 2018Appropriate Device Problem Term/Code Not Available; Appropriate Device Problem Term/Code Not Available
ON (B)(6) 2014, THIS PATIENT UNDERWENT ENDOVASCULAR TREATMENT FOR AN ABDOMINAL AORTIC ANEURYSM MEASURING 65MM IN DIAMETER, AND WAS IMPLANTED WITH GORE® EXCLUDER® AAA ENDOPROSTHESES. THE PATIENT TOLERATED THE PROCEDURE. ON (B)(6) 2014, (B)(6) 2015 AND (B)(6) 2016 THE FOLLOW UP COMPUTED TOMOGRAPHY SCANS DETERMINED THAT THE MAXIMUM DIAMETER OF AORTIC ANEURYSM/LESION WAS 62MM. IT WAS REPORTED THAT ON (B)(6) 2016, A DISTAL TYPE I ENDOLEAK FROM THE RIGHT ILIAC ARTERY WAS IDENTIFIED AND THE PATIENT UNDERWENT ENDOVASCULAR PROCEDURE USING MEDTRONIC DEVICES. THE ENDOLEAK WAS RESOLVED. THE PATIENT TOLERATED THE PROCEDURE. ACCORDING TO THE PHYSICIAN, REMODELING OF THE RIGHT COMMON ILIAC ARTERY AND THE ANEURYSMAL SAC CAUSED THE ENDOLEAK.
Patient problems: Aneurysm
MAUDE report 7779419 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under P020004. One submission often covers many models, so check the product and lot details in each record.
- Z-0995-2020 · Jan 6, 2020 · TerminatedGORE EXCLUDER AAA Endoprosthesis
- Z-0996-2020 · Jan 6, 2020 · TerminatedGORE EXCLUDER Iliac Branch Endoprosthesis (IBE)
Other System, Endovascular Graft, Aortic Aneurysm Treatment devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page